| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $255K | -64.9% |
| SG&A Expense | $4.9M | +70.5% |
| Operating Income | -$5.1M | -43.0% |
| Interest Expense | $9K | -45.6% |
| Income Tax | $2K | — |
| Net Income | -$6.1M | -69.5% |
| EPS (Diluted) | -$1.26 | +20.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Current Assets | $5.2M | +352.1% |
| Total Assets | $12.7M | +1011.6% |
| Current Liabilities | $1.3M | +318.8% |
| Total Liabilities | $1.8M | +456.8% |
| Stockholders' Equity | $9.7M | +1068.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.1M | +3.0% |
| Investing Cash Flow | -$3.2M | — |
| Financing Cash Flow | $10.3M | — |